Summary
The computed 12-month bankruptcy probability of JML PHARMA is 2.1% (moderate). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- JML PHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaamse Gewest, 3090 Overijse,Riddersdal 15” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “Tenzij anders of restrictiever bepaald, zijn in relaties met derden de bevoegdheden van de bestuurder(s) het meest uitgebreid om in alle…”
- Board ruleHow the board is made up, meets and takes decisions.
- 2 provisions in the deed
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- One provision in the deed
Meetings and financial year
- Financial yearThe twelve-month period the company draws up its annual accounts for.
- From 1 January to 31 December
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Fourth Wednesday of June at 19:00
Oversight and winding up
- Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one.
- No statutory auditor
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Andere partners unaniem, leidt niet tot ontbinding, blijft bestaan tussen andere partners” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- One provision in the deed